ClinicalTrials.govpublic full text
Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®
breast cancer, pharmacokinetics, anti-her-2 human monoclonal antibody, herceptin, gb221, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980039
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.